Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
Inspire Medical Systems (NYSE: INSP) announced that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on Friday, June 26, 2026.
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) announced that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on Friday, June 26, 2026. The company is scheduled to present at 10:00 a.m. Eastern Time, with a live webcast and two-week replay available.
Positive
- None.
Negative
- None.
Details
News Market Reaction – INSP
On Jun 12, the day this news came out, INSP closed 0.61% above the previous close.
Data tracked by StockTitan Argus for the Jun 12 session.
Key Figures
- Event date
- June 26, 2026
- Wells Fargo 2026 MedTech Innovation Spotlight presentation date
- Presentation time
- 10:00 a.m. Eastern Time
- Scheduled start time for the Wells Fargo Spotlight presentation
- Webcast replay window
- Two weeks
- Replay availability period on Inspire’s investor website
- Current price
- $42.44
- Pre-news trading level vs 52-week range
- 52-week high
- $147.03
- Upper end of 52-week trading range
- 52-week low
- $38.91
- Lower end of 52-week trading range
- Market cap
- $1,218,220,109
- Equity value before Wells Fargo Spotlight news
- 20-day avg volume
- 1,157,845 shares
- Liquidity benchmark for recent trading
Historical Context
-
Q1 2026 results with lowered full-year revenue guidance and headwinds.
-
Announcement of presentation at BofA Securities 2026 Healthcare Conference.
-
Scheduling of Q1 2026 earnings release and conference call details.
-
Planned presentation at KeyBanc Capital Markets Healthcare Forum.
-
Strong 4Q25 and FY 2025 results with updated 2026 revenue guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
obstructive sleep apnea medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, June 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on Friday, June 26, 2026.
Inspire is scheduled to speak at 10:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.